Publication Name	World Journal of Diabetes
Manuscript ID	28682
Country	India

Received	2016-07-11 09:22
Peer-Review Started	2016-07-14 18:24
To Make the First Decision	2016-09-06 11:05
Return for Revision	2016-09-12 15:27
Revised	2016-09-26 22:52
Second Decision	2016-11-10 14:23
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-11-22 15:35
Articles in Press	2016-11-22 15:35
Publication Fee Transferred
Edit the Manuscript by Language Editor	2016-12-21 14:51
Typeset the Manuscript	2017-03-07 09:28
Publish the Manuscript Online	2017-03-09 16:09

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Prospective Study
Article Title	Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients
Manuscript Source	Invited Manuscript
All Author List	Neerja Aggarwal, Pawan Kumar Kare, Parul Varshney, Om Prakash Kalra, Sri Venkata Madhu, Basu Dev Banerjee, Anil Yadav, Alpana Raizada and Ashok Kumar Tripathi
Funding Agency and Grant Number	Funding Agency Grant Number Department of Biotechnology, Government of India, New Delhi (DBT Project) BT/PR 4640/MED/30/716/2012
Corresponding Author	Ashok Kumar Tripathi, PhD, Professor, Biochemistry and Immunology Laboratory, Department of Biochemistry, University College of Medical Sciences (University of Delhi) and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi 110095, India. aktripathiucms@gmail.com
Key Words	Diabetic nephropathy; Angiotensin converting enzyme inhibitor therapy; Renin-angiotensin-aldosterone system gene polymorphisms; Responder; Urinary albumin/creatinine ratio; Albuminuria
Core Tip	Angiotensin converting enzyme (ACE) inhibitors are used as standard therapy in patients with diabetic nephropathy (DN) and reported to have reno-protective effect in these patients; however, the response to ACE inhibitor therapy is not uniform in all patients. We investigated whether ACE I/D and angiotensinogen gene (AGT) M235T polymorphisms of genes of the renin-angiotensin-aldosterone system are associated with variable response to ACE inhibitors in DN patients. ACE inhibitor treatment in DN patients caused a significant reduction in urinary protein excretion and was found independent of ACE I/D and AGT M235T polymorphisms.
Publish Date	2017-03-09 16:09
Citation	Aggarwal N, Kare PK, Varshney P, Kalra OP, Madhu SV, Banerjee BD, Yadav A, Raizada A, Tripathi AK. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes 2017; 8(3): 112-119
URL	http://www.wjgnet.com/1948-9358/full/v8/i3/112.htm
DOI	http://dx.doi.org/10.4239/wjd.v8.i3.112

Full Article (PDF)	WJD-8-112.pdf
Full Article (Word)	WJD-8-112.doc
Manuscript File	28682-Review.docx
Answering Reviewers	28682-Answering reviewers.pdf
Audio Core Tip	28682-Audio core tip.mp3
Biostatistics Review Certificate	Biostatistics_Statement_20160710165641.pdf
Clinical Trial Registration Statement	DeclarationOf_HelsinkiConformation_Statement_20160710170410.pdf
Conflict-of-Interest Disclosure Form	28682-Conflict-of-interest statement.pdf
Copyright License Agreement	28682-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	28682-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20160710165855.pdf
Institutional Review Board Approval Form or Document	28682-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	28682-Language certificate.pdf
Peer-review Report	28682-Peer-review(s).pdf
Scientific Misconduct Check	28682-Scientific misconduct check.pdf
Scientific Editor Work List	28682-Scientific editor work list.pdf